Patents by Inventor Andrew Forrest

Andrew Forrest has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12233740
    Abstract: An approach is provided for dynamically controlling power distribution amongst a plurality of charging station ports based on one or more objectives. A method includes obtaining input data, wherein the input data includes at least one of: user data associated with one or more current charging station users, or non-user data that is not associated with the current charging station users. The method includes processing the input data through one or more machine learning engines, wherein the one or more machine learning engines are trained to determine a particular power distribution, among the plurality of charging station ports, that achieves one or more objectives. The method includes configuring the plurality of charging station ports according to the particular power distribution. The particular power distribution specifies a maximum charging rate or a percentage of a power budget for each of the plurality of charging station ports.
    Type: Grant
    Filed: June 14, 2022
    Date of Patent: February 25, 2025
    Assignee: Volta Charging, LLC
    Inventors: David J. Klein, Andrew Forrest, Praveen K. Mandal
  • Publication number: 20220396172
    Abstract: An approach is provided for dynamically controlling power distribution amongst a plurality of charging station ports based on one or more objectives. A method includes obtaining input data, wherein the input data includes at least one of: user data associated with one or more current charging station users, or non-user data that is not associated with the current charging station users. The method includes processing the input data through one or more machine learning engines, wherein the one or more machine learning engines are trained to determine a particular power distribution, among the plurality of charging station ports, that achieves one or more objectives. The method includes configuring the plurality of charging station ports according to the particular power distribution. The particular power distribution specifies a maximum charging rate or a percentage of a power budget for each of the plurality of charging station ports.
    Type: Application
    Filed: June 14, 2022
    Publication date: December 15, 2022
    Inventors: David J. Klein, Andrew Forrest, Praveen K. Mandal
  • Patent number: 9422331
    Abstract: Disclosed are compounds of Formula I or pharmaceutically acceptable salts thereof, wherein W, Y, Z, R1, R2, R3, R4 and R5 are described herein, and methods of using said compounds in the treatment of cancer.
    Type: Grant
    Filed: September 16, 2013
    Date of Patent: August 23, 2016
    Assignee: HOFFMANN-LA ROCHE INC.
    Inventors: Andrew Forrest Donnell, Robert Kester, Yan Lou, John Anthony, Stacy Remiszewski
  • Publication number: 20150225449
    Abstract: Disclosed are compounds of Formula I or pharmaceutically acceptable salts thereof, wherein W, Y, Z, R1, R2, R3, R4 and R5 are described herein, and methods of using said compounds in the treatment of cancer.
    Type: Application
    Filed: September 16, 2013
    Publication date: August 13, 2015
    Inventors: Andrew Forrest Donnell, Robert Kester, Yan Lou, John Anthony, Stacy Remiszewski
  • Patent number: 9078885
    Abstract: A pharmaceutical composition adapted for pulmonary administration by inhalation is described, wherein the composition comprises a glitazone and one or more pharmaceutically acceptable carriers and/or excipients, wherein the glitazone content of the composition consists of at least 95% by weight of the 5R enantiomer and less than 5% by weight of the 5S enantiomer, and wherein the glitazone is pioglitazone or rosiglitazone or a pharmaceutically acceptable salt thereof, and wherein the glitazone is in the form of microparticles.
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: July 14, 2015
    Assignee: Pulmagen Therapeutics (Inflammation) Limited
    Inventors: Harry Finch, Craig Fox, Mohammed Sajad, Monique Bondil Van Niel, Andrew Forrest
  • Publication number: 20140248357
    Abstract: A pharmaceutical composition adapted for pulmonary administration by inhalation is described, wherein the composition comprises a glitazone and one or more pharmaceutically acceptable carriers and/or excipients, wherein the glitazone content of the composition consists of at least 95% by weight of the 5R enantiomer and less than 5% by weight of the 5S enantiomer, and wherein the glitazone is pioglitazone or rosiglitazone or a pharmaceutically acceptable salt thereof, and wherein the glitazone is in the form of microparticles.
    Type: Application
    Filed: April 7, 2014
    Publication date: September 4, 2014
    Applicant: PULMAGEN THERAPEUTICS (INFLAMMATION) LIMITED
    Inventors: Harry Finch, Craig Fox, Mohammed Sajad, Monique Bondil Van Niel, Andrew Forrest
  • Patent number: 8815837
    Abstract: There is provided a pharmaceutical composition that is adapted for pulmonary administration by inhalation, which composition comprises a glitazone, such as pioglitazone or rosiglitazone, and one or more pharmaceutically acceptable carriers and/or excipients, and wherein the glitazone content of the composition consists of at least 95% by weight of the 5R enantiomer and less than 5% by weight of the 5S enantiomer. There is also provided a use and kit.
    Type: Grant
    Filed: June 29, 2012
    Date of Patent: August 26, 2014
    Assignee: Pulmagen Therapeutics (Inflammation) Limited
    Inventors: Harry Finch, Craig Fox, Mohammed Sajad, Monique Bondil Van Niel, Andrew Forrest
  • Patent number: 8746699
    Abstract: A novelty game that utilizes a plurality of alphanumeric-shaped playing pieces. Each playing piece has a body shaped as a letter or number. The body has a flat face surface, a parallel rear surface, and side edges that interconnect the face surface to the rear surface. The width of the side edges is large enough to enable each playing piece to stand upright on-edge and unsupported. A plurality of mechanical connectors are present on the playing pieces. The connectors enable each playing piece to physically interconnect with at least two others of the playing pieces to form an assemblage of letters or numbers word. When a conjoined assemblage is formed, only one or some of the playing pieces touch the ground. Most are supported in the air as the playing pieces build atop one another.
    Type: Grant
    Filed: January 22, 2013
    Date of Patent: June 10, 2014
    Assignee: Forrest-Pruzan Creative LLC
    Inventors: Alan Pruzan, Andrew Forrest, Jay Wheatley
  • Patent number: 8741894
    Abstract: Provided herein are arylsulfonamides that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disorder, disease, or condition.
    Type: Grant
    Filed: March 17, 2011
    Date of Patent: June 3, 2014
    Assignee: Axikin Pharmaceuticals, Inc.
    Inventors: Tai Wei Ly, Garrett Thomas Potter, Jared Andrew Forrester
  • Patent number: 8658642
    Abstract: Provided herein are arylsulfonamides that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disorder, disease, or condition.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: February 25, 2014
    Assignee: Axikin Pharmaceuticals, Inc.
    Inventors: Tai Wei Ly, Jared Andrew Forrester
  • Publication number: 20130290013
    Abstract: Systems and methods for providing medical identification tags wearable by a person that include barcodes (e.g., Quick Response (QR) barcodes, or the like) to provide personal medical information to users (e.g., first responders) with mobile devices capable of scanning the barcodes. The system also facilitates automatic notifications to relatives or others associated with the wearer of the medical identification tag when the barcode is scanned, which may indicate an emergency condition. Wearers of the medical identification tags may modify or update the stored personal medical information as needed.
    Type: Application
    Filed: April 24, 2013
    Publication date: October 31, 2013
    Applicant: Virginia Mason Medical Center
    Inventor: Andrew Forrester
  • Patent number: 8420639
    Abstract: Provided herein are arylsulfonamides that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disorder, disease, or condition.
    Type: Grant
    Filed: April 21, 2010
    Date of Patent: April 16, 2013
    Assignee: Axikin Pharmaceuticals, Inc.
    Inventors: Tai Wei Ly, Jared Andrew Forrester
  • Publication number: 20120264787
    Abstract: There is provided a pharmaceutical composition that is adapted for pulmonary administration by inhalation, which composition comprises a glitazone, such as pioglitazone or rosiglitazone, and one or more pharmaceutically acceptable carriers and/or excipients, and wherein the glitazone content of the composition consists of at least 95% by weight of the 5R enantiomer and less than 5% by weight of the 5S enantiomer. There is also provided a use and kit.
    Type: Application
    Filed: June 29, 2012
    Publication date: October 18, 2012
    Applicant: Pulmagen Therapeutics (Inflammation) Limited
    Inventors: Harry FINCH, Craig FOX, Mohammed SAJAD, Monique Bodil VAN NIEL, Andrew FORREST
  • Patent number: 8236786
    Abstract: There is provided a pharmaceutical composition that is adapted for pulmonary administration by inhalation, which composition comprises a glitazone, such as pioglitazone or rosiglitazone, and one or more pharmaceutically acceptable carriers and/or excipients, and wherein the glitazone content of the composition consists of at least 95% by weight of the 5R enantiomer and less than 5% by weight of the 5S enantiomer. There is also provided a use and kit.
    Type: Grant
    Filed: August 4, 2010
    Date of Patent: August 7, 2012
    Assignee: Pulmagen Therapeutics (Inflammation) Limited
    Inventors: Harry Finch, Craig Fox, Mohammed Sajad, Monique Bodil Van Niel, Andrew Forrest
  • Publication number: 20110230487
    Abstract: Provided herein are arylsulfonamides that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disorder, disease, or condition.
    Type: Application
    Filed: March 17, 2011
    Publication date: September 22, 2011
    Inventors: Tai Wei LY, Garrett Thomas Potter, Jared Andrew Forrester
  • Publication number: 20110053986
    Abstract: There is provided a pharmaceutical composition that is adapted for pulmonary administration by inhalation, which composition comprises a glitazone, such as pioglitazone or rosiglitazone, and one or more pharmaceutically acceptable carriers and/or excipients, and wherein the glitazone content of the composition consists of at least 95% by weight of the 5R enantiomer and less than 5% by weight of the 5S enantiomer. There is also provided a use and kit.
    Type: Application
    Filed: August 4, 2010
    Publication date: March 3, 2011
    Inventors: Harry Finch, Craig Fox, Mohammed Sajad, Monique Bodil Van Niel, Andrew Forrest
  • Patent number: 7828293
    Abstract: A game assembly and its method of play. The game assembly has a game board. A three-dimensional underlay is positioned under the game board. Openings are formed through the game board that enable a person to see into the underlay. The underlay is comprised of a basin that is partially occupied with fill material. Search objects are mixed with the fill material. Sometimes the search objects are covered by the fill material, at other times they are not. Cover structures are provided. The cover structures selectively cover the openings in the game board. To play the game, a player selects a search object. A player also selects a cover structure. The cover structure selected by the player is removed and the player looks through the exposed opening for the selected search object. The game is won when a predetermined number of search objects are found by a single player.
    Type: Grant
    Filed: May 31, 2009
    Date of Patent: November 9, 2010
    Inventors: Alan Pruzan, Andrew Forrest, Jay Wheatley
  • Publication number: 20100273795
    Abstract: Provided herein are arylsulfonamides that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disorder, disease, or condition.
    Type: Application
    Filed: April 21, 2010
    Publication date: October 28, 2010
    Applicant: Axikin Pharmaceuticals, Inc.
    Inventors: Tai Wei Ly, Jared Andrew Forrester
  • Publication number: 20080090773
    Abstract: A compound of formula (I) or a pharmaceutically acceptable derivative thereof, having antimicrobial activity, processes for their preparation, compositions containing them and to their use in medicine.
    Type: Application
    Filed: November 9, 2005
    Publication date: April 17, 2008
    Inventors: Desmond Best, John Elder, Andrew Forrest, Robert Sheppard, Andrea Fajdetic
  • Publication number: 20070213362
    Abstract: A method of inhibiting MetRS activity comprises administering to a patient in need thereof a MetRS inhibiting effective amount of a compound of the formula (I). A method of treating a resistant or multiply-resistant E. faecalis infection, a resistant or multiply-resistant S. aureus infection, and/or a resistant or multiply-resistant S. epidermidis infection comprises administering to a patient in need thereof an antibacterially effective amount of a compound of the formula (I).
    Type: Application
    Filed: May 21, 2007
    Publication date: September 13, 2007
    Applicant: Replidyne, Inc.
    Inventors: John Berge, Andrew Forrest, Dieter Hamprecht, Richard Jarvest